[go: up one dir, main page]

NO20063106L - MRI-kontrastmediumsammensetning for oral administrasjon - Google Patents

MRI-kontrastmediumsammensetning for oral administrasjon

Info

Publication number
NO20063106L
NO20063106L NO20063106A NO20063106A NO20063106L NO 20063106 L NO20063106 L NO 20063106L NO 20063106 A NO20063106 A NO 20063106A NO 20063106 A NO20063106 A NO 20063106A NO 20063106 L NO20063106 L NO 20063106L
Authority
NO
Norway
Prior art keywords
contrast medium
mri contrast
medium composition
oral administration
promoter
Prior art date
Application number
NO20063106A
Other languages
English (en)
Norwegian (no)
Inventor
Nils-Olof Johansson
Original Assignee
Cmc Contrast Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cmc Contrast Ab filed Critical Cmc Contrast Ab
Publication of NO20063106L publication Critical patent/NO20063106L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO20063106A 2003-12-19 2006-07-04 MRI-kontrastmediumsammensetning for oral administrasjon NO20063106L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303429A SE527491C2 (sv) 2003-12-19 2003-12-19 Kontraktsmedelskomposition för magnetisk resonanstomografi för oral administration
PCT/SE2004/001644 WO2005058375A1 (en) 2003-12-19 2004-11-10 Mri contrast medium composition for oral administration

Publications (1)

Publication Number Publication Date
NO20063106L true NO20063106L (no) 2006-09-18

Family

ID=30768766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063106A NO20063106L (no) 2003-12-19 2006-07-04 MRI-kontrastmediumsammensetning for oral administrasjon

Country Status (15)

Country Link
US (1) US20070065520A1 (zh)
EP (2) EP2060273B1 (zh)
JP (1) JP4731493B2 (zh)
KR (1) KR101131362B1 (zh)
AT (1) ATE499117T1 (zh)
AU (1) AU2004298396B2 (zh)
CA (1) CA2549890C (zh)
DE (1) DE602004031569D1 (zh)
DK (1) DK2060273T3 (zh)
ES (1) ES2363917T3 (zh)
NO (1) NO20063106L (zh)
RU (1) RU2361618C2 (zh)
SE (1) SE527491C2 (zh)
TW (1) TWI334787B (zh)
WO (1) WO2005058375A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011003818A2 (en) 2009-07-06 2011-01-13 Cmc Contrast Ab Diagnostic method
ES2764408T3 (es) 2013-08-28 2020-06-03 Promethera Biosciences S A / N V Procedimiento para la producción de células progenitoras hepáticas adultas
JP2017530697A (ja) 2014-08-28 2017-10-19 プロメセラ バイオサイエンシーズ エス．アー．／エンヌ．フェー． 成体肝前駆細胞を作製する方法
RU2577298C1 (ru) * 2014-10-01 2016-03-10 Общество с ограниченной ответственностью "МедКонтрастСинтез" (ООО "МедКонтрастСинтез") Гепатотропное магнитно-резонансное средство
KR101864992B1 (ko) * 2017-03-09 2018-07-04 국립암센터 Mri 노이즈 제거용 조성물 및 이를 이용한 패드
KR102381029B1 (ko) * 2019-04-05 2022-03-31 연세대학교 산학협력단 대사체를 유효성분으로 포함하는 신규한 조영제 조성물
US10912847B2 (en) 2019-06-07 2021-02-09 Ascelia Pharma AB Compressed solid composition for MRI

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863898A (en) * 1986-02-06 1989-09-05 Albion International, Inc. Amino acid chelated compositions for delivery to specific biological tissue sites
NO884225L (no) 1987-09-25 1989-03-28 Salutar Inc Nmr-bildedannelse mn(ii)- koordinasjonsforbindelser.
WO1996005867A2 (en) 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method

Also Published As

Publication number Publication date
RU2361618C2 (ru) 2009-07-20
EP1694367A1 (en) 2006-08-30
TWI334787B (en) 2010-12-21
EP2060273A3 (en) 2009-09-30
KR101131362B1 (ko) 2012-04-04
AU2004298396B2 (en) 2010-06-17
EP2060273A2 (en) 2009-05-20
US20070065520A1 (en) 2007-03-22
SE527491C2 (sv) 2006-03-21
JP4731493B2 (ja) 2011-07-27
ES2363917T3 (es) 2011-08-19
CA2549890A1 (en) 2005-06-30
CA2549890C (en) 2012-09-18
DE602004031569D1 (de) 2011-04-07
SE0303429L (sv) 2005-06-20
ATE499117T1 (de) 2011-03-15
DK2060273T3 (da) 2011-05-23
JP2007514740A (ja) 2007-06-07
TW200520777A (en) 2005-07-01
RU2006126072A (ru) 2008-01-27
EP2060273B1 (en) 2011-02-23
WO2005058375A1 (en) 2005-06-30
AU2004298396A1 (en) 2005-06-30
SE0303429D0 (sv) 2003-12-19
KR20070027501A (ko) 2007-03-09

Similar Documents

Publication Publication Date Title
NO20063106L (no) MRI-kontrastmediumsammensetning for oral administrasjon
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
NO20065329L (no) Fremstilling av pregabalin og beslektede forbindelser.
IL180896A0 (en) Method of tumour imaging
IL171343A (en) Compound 1, 2, 4 - Oxadiazole Benzoic Acid, a pharmaceutical composition containing it, a method for testing the compound, and its use in the preparation of a drug for the treatment of early-onset disease before the end codon
IL198783A0 (en) Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
WO2002085903A3 (en) Amyloid plaque aggregation inhibitors and diagnostic imaging agents
IS8395A (is) Fjölvasýklískar karboxýlsýrur og asýlsúlfónamíð sem hindrar á lifrabólgu C eftirmyndun
BRPI0608376A8 (pt) composição de ligação, método de uso de uma composição de ligação, e, kit de detecção
MY151134A (en) Improved oral compositions comprising zinc citrate and / or tocopherol agents
SG149895A1 (en) Contrast agents for myocardial perfusion imaging
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
WO2004091497A3 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
DK2157192T3 (da) Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner)
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
BRPI0617219B8 (pt) método automatizado para a preparação de uma composição radiofarmacêutica estéril marcada com 123i, e, cassete estéril
SG152254A1 (en) Contrast agents for myocardial perfusion imaging
NO20041059L (no) Kombinasjon av utvalgte opioder med muskarinantagonister for behandling av urininkontinens
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
ATE529445T1 (de) Biokinetik zur schnellen beseitigung von polypeptiden
DE60207288D1 (de) Gewebespezifische fluoreszierende chelate

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: BRYN AARFLOT AS, POSTBOKS 449 SENTRUM, 0104 OSLO,

FC2A Withdrawal, rejection or dismissal of laid open patent application